Amy Brideau-Andersen

The University of Texas at Dallas — United States

Medicine · Health Sciences

8h-index573citations40works2.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Botulinum Toxin and Related Neurological Disorders(29), Neurological disorders and treatments(16), Hereditary Neurological Disorders(9), Parkinson's Disease Mechanisms and Treatments(4), Migraine and Headache Studies(4)

Publications40 total

OnabotulinumtoxinA inhibits dysregulation of descending pain modulation following mild traumatic brain injury in mice
The Journal of Headache and Pain·2025Open Access
OnabotulinumtoxinA alters pro- and anti-inflammatory dural macrophage response to CSD in female mice
Cephalalgia·2025· 3 citedOpen Access
Botulinum Neurotoxin A Signaling in Pain Modulation Within Human Sensory Neurons
Journal of Neurochemistry·2025· 1 cited
Author response for "Botulinum Neurotoxin A Signaling in Pain Modulation Within Human Sensory Neurons"
2025
Botulinum Neurotoxin A1 Signaling in Pain Modulation within Human Sensory Neurons
2025Open Access
Preclinical Evaluation of Botulinum Toxin Type E (TrenibotulinumtoxinE) Using the Mouse Digit Abduction Score (DAS) Assay
Toxins·2025· 3 citedOpen Access
Botulinum neurotoxin type DC (BoNT/DC) cleavage of VAMP3 reduces melanin production in melanocytes
Toxicon·2025· 1 citedOpen Access
Update on Non-Interchangeability of Botulinum Neurotoxin Products
Toxins·2024· 21 citedOpen Access
Reversal of Botulinum Neurotoxin Type A–Induced Muscle Paralysis by a Chimeric Toxin Delivery System
Toxicon·2024
A Cell Penetrating Peptide (CPP), Synthesized to Match the Sequence of Revance Rtp004, Does not Decrease 150 Kd BoNT-A Toxin Adsorption to Surfaces
Toxicon·2024
Evaluation of Botulinum Neurotoxin Type E Preparation (TrenibotulinumtoxinE) in the Mouse Digit Abduction Score (DAS) Assay
Toxicon·2024· 1 cited
Botulinum Neurotoxin Type DC (BoNT/DC) Blocks Melanocyte Melanogenesis
Toxicon·2024
Botulinum neurotoxins: Future innovations
Medicine·2023· 5 citedOpen Access
A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA
Clinical Cosmetic and Investigational Dermatology·2023· 7 citedOpen Access
OnabotulinumtoxinA effects on trigeminal nociceptors
Cephalalgia·2023· 18 citedOpen Access
Botulinum Neurotoxin Type A Directly Affects Sebocytes and Modulates Oleic Acid-Induced Lipogenesis
Toxins·2022· 7 citedOpen Access
Botulinum Neurotoxin Accelerates the Resolution of Bacterial Skin Infections in Mice
Toxicon·2022
Botulinum Neurotoxin Type A Directly Affects Sebocytes and Modulates Oleic Acid–Induced Lipogenesis
Toxicon·2022
Reengineering the specificity of the highly selective Clostridium botulinum protease via directed evolution
Scientific Reports·2022· 10 citedOpen Access
A Cell-Penetrating Peptide (CPP) Did Not Decrease 150-kDa BoNT/A Toxin Adsorption to Surfaces or Increase Toxin Potency or Duration in a Prototype Formulation (2095)
Neurology·2021
page 1 of 2Next →

Frequent Co-authors

Ron S. Broide(20), Lance E. Steward(12), Mitchell F. Brin(12), D. Rupp(11), Shiazah Malik(9), Edwin Vazquez‐Cintron(9), Birgitte Jacky(8), Catherine Rhéaume(6), Greg Nicholson(6), Mariana Nelson(4), Nicholas G. James(4), David M. Jameson(4), Linh Le(4), Birgitte P. S. Jacky(4), Birgitte Sondergaard(4), Celina Nino(4), Bethany J. Sanstrum(3), David Canty(3), Rebekah P. Dyer(3), Hariny M. Isoda(3)